Pathstone Holdings, LLC Arbutus Biopharma Corp Transaction History
Pathstone Holdings, LLC
- $22.2 Billion
- Q4 2024
A detailed history of Pathstone Holdings, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Pathstone Holdings, LLC holds 11,088 shares of ABUS stock, worth $36,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,088
Previous 11,250
1.44%
Holding current value
$36,368
Previous $43,000
16.28%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ABUS
# of Institutions
165Shares Held
102MCall Options Held
649KPut Options Held
666K-
Morgan Stanley New York, NY22.6MShares$74.1 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.2MShares$43.4 Million22.74% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$37.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$29.5 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$28.7 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $492M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...